Chemours (CC) Equity Average (2014 - 2026)

Chemours' Equity Average history runs 13 years deep, the most recent figure standing at $232.5 million for Q1 2026.

• In Q1 2026, Equity Average fell 59.17% year-over-year to $232.5 million; the TTM figure through Mar 2026 stood at $232.5 million (down 59.17% YoY), while the FY2025 annual figure was $411.0 million, down 36.43% from the prior year.
• Equity Average was $232.5 million for Q1 2026 at Chemours, down from $262.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.2 billion in Q3 2022 to a low of -$15.0 million in Q2 2024.
• Historically, Equity Average has averaged $737.6 million across 5 years, with a median of $779.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Average tumbled 101.47% in 2024, then soared 2750.0% in 2025.
• A 5-year view of Equity Average shows it stood at $1.2 billion in 2022, then sank by 38.52% to $735.0 million in 2023, then soared by 57.89% to $1.2 billion in 2024, then slumped by 77.42% to $262.0 million in 2025, then slipped by 11.26% to $232.5 million in 2026.
• The last three Equity Average figures came in at $232.5 million (Q1 2026), $262.0 million (Q4 2025), and $251.0 million (Q3 2025), per Business Quant data.